Review



differentiation 36  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    R&D Systems differentiation 36
    Differentiation 36, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 14 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd/Recombinant+Human+CD36%2FSR-B3+Fc+Chimera+Protein%2C+CF/pmc13064270-68-11-24
    Average 94 stars, based on 14 article reviews
    differentiation 36 - by Bioz Stars, 2026-11
    94/100 stars

    Images

    Related Articles

    Control:

    Article Title: The LIF-LIFR Axis Promotes Liver Regeneration via Modulation of Angiogenesis and HGF Release from LSECs
    Article Snippet: .. The proteins which included hLIF (Abcam, #ab287941), hVEGF (R&D system, #293-VE), hOSM (R&D system, #8475-OM), hCT1 (R&D system, 612-CD-010), IL-6 (PeproTech, 200-06), hHGF(R&D system, 294-HG), mHGF (R&D system, 2207-HG-025), EGF (R&D system, 236-EG), aLIF (UCSD), MAb mouse IgG2a isotype control (BioXcell,C1.18.4, #BE0085), anti-VEGF antibody B20-4.1.1 (Genentech) were added to cells at various concentrations, as indicated in the figures. .. After 5 or 6 days, cells were incubated with 18 μL Resazurin solution (Biotium, 30025-2) for 4 h. Fluorescence was measured at 530-nm excitation wavelength and 590-nm emission wavelength using the plate reader SpectraMax M5 (Molecular Devices, Sunnyvale, CA).

    Article Title: Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction.
    Article Snippet: For Review Only Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction Supplementary materials and data analyses Reagents and materials used: Reagent/materials Vendor Catalog number Notes Mouse lung dissociation kit Miltenyi Biotec., Bergisch Gladbach, Germany #130-095-927 RIPA Buffer Invitrogen., Carlsbad, CA #1861278 HALTTM phosphatase inhibitor cocktail Invitrogen., Carlsbad, CA #1862495 HUVECs Lonza., Morristown, NJ #CC-2519 ON-TARGETplus SiRNA CD44 (Human) Dharmacon Reagents., Cambridge, United Kingdom #L-009999-000010 LipofectamineTM RNAiMAX transfection reagent Invitrogen., Carlsbad, CA #13778150 Opti-MEMTM medium Gibco., Grand Island, NY #11058021 phorbol 12-myristate 13-acetate Sigma-aldrich., St. Louis, MO #524400 Ad. hADAM17 Vector biolabs., Devault, PA ADV-200349 #2001 Ad-CMV-null Vector biolabs., Devault, PA #1300 Recombinant active ADAM17 R&D Systems., Minneapolis, MN #930-ADB-010 Ibidi μ-Slide VI 0.4 Luer channels Ibidi., Fitchburg, WI #80186 Ibidi μ-Slide I 0.6 Luer channels Ibidi., Fitchburg, WI #80606 Fluo-4 Assay Kit Calcium Abcam., Cambridge, United Kingdom #ab228555 Hyaluronidase from bovine testes Sigma-aldrich., St. Louis, MO #H3506 High-capacity carboxyl sensors Nicoya., Kitchener, Canada #SEN-AU100-10-HC- COOH Page 34 of 38 https://mc.manuscriptcentral.com/function Manuscripts submitted to Function 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Downloaded from journals.physiology.org/journal/function (2001:448A:5160:33DE:ADDE:2129:780F:130F) on March 31, 2026. .. For Review Only Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction Protein A Nicoya., Kitchener, Canada #SEN-AU100-10-PROA- KIT Recombinant human CD44-fc chimera R&D Systems., Minneapolis, MN #3660-CD Hyaluronan Lifecore biomedical., Chaska, MN #HA100K-1 Component C Anaspec., Fremont, CA #AS-72085 SensoLyte TACE activity kit Anaspec., Fremont, CA #AS-72085 Human hyaluronan ELISA kit R&D Systems., Minneapolis, MN #DHYAL0 15-well 3D Ibidi μSlides Ibidi., Fitchburg, WI #81506 Antibodies and stains used: Antibodies/stains Working concentration Vendor Catalog RRID Fluo-4 Assay Kit Calcium 1X Abcam., Cambridge, United Kingdom #ab228555 - Anti-mouse CD44LE/AF KM201 antibody – Functional experiment (i.e., FMD) 0.25mg/mL Southern Biotech., Birmingham Alabama #1500-14 RRID:AB_2794779 IgG1-LE/AF isotype control – Functional experiment (i.e., FMD) 0.25mg/mL Southern Biotech., Birmingham Alabama #0116-14 RRID:AB_2793987 CD44 (MEM-263) 1:100 Abcam., Cambridge, United Kingdom #9524 RRID:AB_307310 Anti-ADAM17 1:100 LSbio., Saratoga, CA #B4426 RRID:AB_10796856 Anti-ADAM17 1:100 Abcam., Cambridge, United Kingdom #39162 RRID:AB_722565 Page 35 of 38 https://mc.manuscriptcentral.com/function Manuscripts submitted to Function 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Downloaded from journals.physiology.org/journal/function (2001:448A:5160:33DE:ADDE:2129:780F:130F) on March 31, 2026. .. For Review Only Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction eNOS/NOS type III 1:100 BD Transduction., Franklin Lakes, NJ #610296 RRID:AB_397690 anti-mouse Alexa Fluor 488 1:300–1:500 Invitrogen., Carlsbad, CA #A21202 RRID:AB_141607 anti-mouse Alexa Fluor 647 1:300–1:500 Invitrogen., Carlsbad, CA #A21235 RRID:AB_2535804 anti-rabbit Alexa Fluor 488 1:300–1:500 Invitrogen., Carlsbad, CA #A32731 RRID:AB_2633280 anti-rabbit Alexa Fluor 647 1:300–1:500 Invitrogen., Carlsbad, CA #A21245 RRID:AB_2535813 40,6-diamidino-2phenylindole (DAPI) 1.5nM; 1:1000 SigmaAldrich, Burlington, MA #D9542 - CD44 (E7K2Y) XP (Western blot) 1:1000 Cell Signaling Technology., Danvers, MA #37259 RRID:AB_2750879 Anti-eNOS (phospho Ser1177) (Western blot) 1:1000 Abcam., Cambridge, United Kingdom #184154 RRID:AB_2768154 eNOS (D9A5L) (Western blot) 1:1000 Cell Signaling Technology., Danvers, MA #32027 RRID:AB_2728756 RP-conjugated Goat Anti-Rabbit 1:5000 Bio-Rad., Hercules, CA #1705046 RRID:AB_11125757 Starbright Blue 700 Anti-Rabbit 1:2000 Bio-Rad., Hercules, CA #12004161 RRID:AB_2721073 Starbright Blue 520 Anti-Mouse 1:2000 Bio-Rad., Hercules, CA #12005866 RRID:AB_2934034 Page 36 of 38 https://mc.manuscriptcentral.com/function Manuscripts submitted to Function 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Downloaded from journals.physiology.org/journal/function (2001:448A:5160:33DE:ADDE:2129:780F:130F) on March 31, 2026.

    Article Title: Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction.
    Article Snippet: For Review Only 11 249 Surface plasmon resonance (SPR) 250 To demonstrate that ADAM17 cleaves CD44 and reduces binding to HA, 251 molecular binding was measured using SPR (OpenSPR, Nicoya, Kitchener, Canada). .. 252 To control orientation of recombinant proteins, high-capacity carboxyl sensors (Nicoya) 253 were functionalized with protein-A (40ng/μL; Nicoya), which then bound the fc region of 254 recombinant human CD44-fc chimera (CD44-r-fc; 5ng/μL; R&D systems). .. Protein-A 255 (Nicoya) was coupled to the sensor using sodium acetate (pH=5).

    Article Title: The protease cathepsin K can debulk the cancer glycocalyx
    Article Snippet: A minimum of 20,000 live, single cells up to 180 μl of sample were analyzed using a MACSQuant Analyzer 10 flow cytometer (Miltenyi Biotec). .. Recombinant PSGL-1 (10 μg; Sino Biological; 13863-H08H), recombinant MUC1 (Sino Biological; 12123-H05H), recombinant CD43 (R&D Systems; 9680-CD-050), fetuin (Promega; V4961), and purified MUC16 (purified from OVCAR-3 as above) were mixed with CTSK or PBS control at a 1:50 CTSK:substrate molar ratio in 1:1 PBS:100 mM sodium acetate with a final pH of 5 (buffer pHed as above). ..

    Recombinant:

    Article Title: Alpha-1 antitrypsin–glucocorticoid receptor axis: a new pathway in immune modulation
    Article Snippet: .. Recombinant proteins used included human LRP1 cluster IV (#5395-L4), cluster of differentiation 36 (CD36; #1955-CD), SR-BI (#8114-SRB), and transferrin receptor (TfR, #2474-TR) all from R&D Systems, Minneapolis, MN, USA), and human glucocorticoid receptor (GR; #A15663, Thermo Fisher Scientific), as previously described (Bai et al. ). ..

    Article Title: Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction.
    Article Snippet: For Review Only Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction Supplementary materials and data analyses Reagents and materials used: Reagent/materials Vendor Catalog number Notes Mouse lung dissociation kit Miltenyi Biotec., Bergisch Gladbach, Germany #130-095-927 RIPA Buffer Invitrogen., Carlsbad, CA #1861278 HALTTM phosphatase inhibitor cocktail Invitrogen., Carlsbad, CA #1862495 HUVECs Lonza., Morristown, NJ #CC-2519 ON-TARGETplus SiRNA CD44 (Human) Dharmacon Reagents., Cambridge, United Kingdom #L-009999-000010 LipofectamineTM RNAiMAX transfection reagent Invitrogen., Carlsbad, CA #13778150 Opti-MEMTM medium Gibco., Grand Island, NY #11058021 phorbol 12-myristate 13-acetate Sigma-aldrich., St. Louis, MO #524400 Ad. hADAM17 Vector biolabs., Devault, PA ADV-200349 #2001 Ad-CMV-null Vector biolabs., Devault, PA #1300 Recombinant active ADAM17 R&D Systems., Minneapolis, MN #930-ADB-010 Ibidi μ-Slide VI 0.4 Luer channels Ibidi., Fitchburg, WI #80186 Ibidi μ-Slide I 0.6 Luer channels Ibidi., Fitchburg, WI #80606 Fluo-4 Assay Kit Calcium Abcam., Cambridge, United Kingdom #ab228555 Hyaluronidase from bovine testes Sigma-aldrich., St. Louis, MO #H3506 High-capacity carboxyl sensors Nicoya., Kitchener, Canada #SEN-AU100-10-HC- COOH Page 34 of 38 https://mc.manuscriptcentral.com/function Manuscripts submitted to Function 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Downloaded from journals.physiology.org/journal/function (2001:448A:5160:33DE:ADDE:2129:780F:130F) on March 31, 2026. .. For Review Only Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction Protein A Nicoya., Kitchener, Canada #SEN-AU100-10-PROA- KIT Recombinant human CD44-fc chimera R&D Systems., Minneapolis, MN #3660-CD Hyaluronan Lifecore biomedical., Chaska, MN #HA100K-1 Component C Anaspec., Fremont, CA #AS-72085 SensoLyte TACE activity kit Anaspec., Fremont, CA #AS-72085 Human hyaluronan ELISA kit R&D Systems., Minneapolis, MN #DHYAL0 15-well 3D Ibidi μSlides Ibidi., Fitchburg, WI #81506 Antibodies and stains used: Antibodies/stains Working concentration Vendor Catalog RRID Fluo-4 Assay Kit Calcium 1X Abcam., Cambridge, United Kingdom #ab228555 - Anti-mouse CD44LE/AF KM201 antibody – Functional experiment (i.e., FMD) 0.25mg/mL Southern Biotech., Birmingham Alabama #1500-14 RRID:AB_2794779 IgG1-LE/AF isotype control – Functional experiment (i.e., FMD) 0.25mg/mL Southern Biotech., Birmingham Alabama #0116-14 RRID:AB_2793987 CD44 (MEM-263) 1:100 Abcam., Cambridge, United Kingdom #9524 RRID:AB_307310 Anti-ADAM17 1:100 LSbio., Saratoga, CA #B4426 RRID:AB_10796856 Anti-ADAM17 1:100 Abcam., Cambridge, United Kingdom #39162 RRID:AB_722565 Page 35 of 38 https://mc.manuscriptcentral.com/function Manuscripts submitted to Function 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Downloaded from journals.physiology.org/journal/function (2001:448A:5160:33DE:ADDE:2129:780F:130F) on March 31, 2026. .. For Review Only Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction eNOS/NOS type III 1:100 BD Transduction., Franklin Lakes, NJ #610296 RRID:AB_397690 anti-mouse Alexa Fluor 488 1:300–1:500 Invitrogen., Carlsbad, CA #A21202 RRID:AB_141607 anti-mouse Alexa Fluor 647 1:300–1:500 Invitrogen., Carlsbad, CA #A21235 RRID:AB_2535804 anti-rabbit Alexa Fluor 488 1:300–1:500 Invitrogen., Carlsbad, CA #A32731 RRID:AB_2633280 anti-rabbit Alexa Fluor 647 1:300–1:500 Invitrogen., Carlsbad, CA #A21245 RRID:AB_2535813 40,6-diamidino-2phenylindole (DAPI) 1.5nM; 1:1000 SigmaAldrich, Burlington, MA #D9542 - CD44 (E7K2Y) XP (Western blot) 1:1000 Cell Signaling Technology., Danvers, MA #37259 RRID:AB_2750879 Anti-eNOS (phospho Ser1177) (Western blot) 1:1000 Abcam., Cambridge, United Kingdom #184154 RRID:AB_2768154 eNOS (D9A5L) (Western blot) 1:1000 Cell Signaling Technology., Danvers, MA #32027 RRID:AB_2728756 RP-conjugated Goat Anti-Rabbit 1:5000 Bio-Rad., Hercules, CA #1705046 RRID:AB_11125757 Starbright Blue 700 Anti-Rabbit 1:2000 Bio-Rad., Hercules, CA #12004161 RRID:AB_2721073 Starbright Blue 520 Anti-Mouse 1:2000 Bio-Rad., Hercules, CA #12005866 RRID:AB_2934034 Page 36 of 38 https://mc.manuscriptcentral.com/function Manuscripts submitted to Function 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Downloaded from journals.physiology.org/journal/function (2001:448A:5160:33DE:ADDE:2129:780F:130F) on March 31, 2026.

    Article Title: Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction.
    Article Snippet: For Review Only 11 249 Surface plasmon resonance (SPR) 250 To demonstrate that ADAM17 cleaves CD44 and reduces binding to HA, 251 molecular binding was measured using SPR (OpenSPR, Nicoya, Kitchener, Canada). .. 252 To control orientation of recombinant proteins, high-capacity carboxyl sensors (Nicoya) 253 were functionalized with protein-A (40ng/μL; Nicoya), which then bound the fc region of 254 recombinant human CD44-fc chimera (CD44-r-fc; 5ng/μL; R&D systems). .. Protein-A 255 (Nicoya) was coupled to the sensor using sodium acetate (pH=5).

    Article Title: The protease cathepsin K can debulk the cancer glycocalyx
    Article Snippet: A minimum of 20,000 live, single cells up to 180 μl of sample were analyzed using a MACSQuant Analyzer 10 flow cytometer (Miltenyi Biotec). .. Recombinant PSGL-1 (10 μg; Sino Biological; 13863-H08H), recombinant MUC1 (Sino Biological; 12123-H05H), recombinant CD43 (R&D Systems; 9680-CD-050), fetuin (Promega; V4961), and purified MUC16 (purified from OVCAR-3 as above) were mixed with CTSK or PBS control at a 1:50 CTSK:substrate molar ratio in 1:1 PBS:100 mM sodium acetate with a final pH of 5 (buffer pHed as above). ..

    Article Title: Alpha-1 antitrypsin-glucocorticoid receptor axis: a new pathway in immune modulation.
    Article Snippet: .. Recombinant proteins used included human LRP1 cluster IV #5395-L4), cluster of differentiation 36 (CD36; #1955-CD), SR-BI (#8114-SRB), and transferrin receptor (TfR, #2474-TR) all from R&D Systems, Minneapolis, MN, USA), and human glucocorticoid receptor (GR; #A15663, Thermo Fisher Scientific), as previously described (Bai et al. 2022). ..

    Article Title: Actomyosin rings constrain CD40 mobility to organize the dendritic cell immunological synapse.
    Article Snippet: .. Glass coverslips (18 mm, #1.5, Marinefeld) were functionalized by coating them with 100 μg/mL human fibronectin (self-isolated from human sera) and 1 μg/mL CCL21 recombinant protein (Peprotech, 300-35), 10 μg/mL anti-MHCII antibody (Invitrogen, 16-5321-85), ), 10 μg/mL anti-ICAM-1 antibody (eBioscience, 16.0542.81) and 10 μg/mL recombinant CD40L protein (R&D Systems, 8230-CL-050/CF), CD27 (R&D Systems, 574-CD-050), OX40 (R&D Systems, 1256-OX-050), 41BB (R&D Systems, 937-4B-050), GITR (R&D Systems, 524-GR-050), LIGHT (R&D Systems, 1794-LT025/CF) in PBS. ..

    Article Title: Bispecific nanoparticle systems for targeting cancer cells
    Article Snippet: .. Cat. No. Immunogen Anti-CD3 CD3 antibody | CD3- Bio-Rad MCA1477 Synthetic peptide 12 sequence derived from cytoplasmic epitope of CD3 (Glu- Arg-Pro-Pro-Pro-Val- Pro-Asn-Pro-Asp-Tyr- Glu-Pro-Cys) Anti-HEr2 Herceptin ® Genentech 440 mg vial — (Trastuzumab) 440 mg CD19 Recombinant Human R&D systems 9269-CD-050 — CD19 Fc Chimera Protein, CF CAR-T cell CD19 scFv-CD22 Promab PM-CAR1050- — scFv-4-1BB-CD3- 1M T2A-RQR8 (Ritiximab suicide switch) .. Cell Lines and Cell Culture Media PC3, SKBR3, and HUVEC cells were obtained from Innoprot.

    Shear:

    Article Title: Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction.
    Article Snippet: For Review Only Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction Supplementary materials and data analyses Reagents and materials used: Reagent/materials Vendor Catalog number Notes Mouse lung dissociation kit Miltenyi Biotec., Bergisch Gladbach, Germany #130-095-927 RIPA Buffer Invitrogen., Carlsbad, CA #1861278 HALTTM phosphatase inhibitor cocktail Invitrogen., Carlsbad, CA #1862495 HUVECs Lonza., Morristown, NJ #CC-2519 ON-TARGETplus SiRNA CD44 (Human) Dharmacon Reagents., Cambridge, United Kingdom #L-009999-000010 LipofectamineTM RNAiMAX transfection reagent Invitrogen., Carlsbad, CA #13778150 Opti-MEMTM medium Gibco., Grand Island, NY #11058021 phorbol 12-myristate 13-acetate Sigma-aldrich., St. Louis, MO #524400 Ad. hADAM17 Vector biolabs., Devault, PA ADV-200349 #2001 Ad-CMV-null Vector biolabs., Devault, PA #1300 Recombinant active ADAM17 R&D Systems., Minneapolis, MN #930-ADB-010 Ibidi μ-Slide VI 0.4 Luer channels Ibidi., Fitchburg, WI #80186 Ibidi μ-Slide I 0.6 Luer channels Ibidi., Fitchburg, WI #80606 Fluo-4 Assay Kit Calcium Abcam., Cambridge, United Kingdom #ab228555 Hyaluronidase from bovine testes Sigma-aldrich., St. Louis, MO #H3506 High-capacity carboxyl sensors Nicoya., Kitchener, Canada #SEN-AU100-10-HC- COOH Page 34 of 38 https://mc.manuscriptcentral.com/function Manuscripts submitted to Function 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Downloaded from journals.physiology.org/journal/function (2001:448A:5160:33DE:ADDE:2129:780F:130F) on March 31, 2026. .. For Review Only Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction Protein A Nicoya., Kitchener, Canada #SEN-AU100-10-PROA- KIT Recombinant human CD44-fc chimera R&D Systems., Minneapolis, MN #3660-CD Hyaluronan Lifecore biomedical., Chaska, MN #HA100K-1 Component C Anaspec., Fremont, CA #AS-72085 SensoLyte TACE activity kit Anaspec., Fremont, CA #AS-72085 Human hyaluronan ELISA kit R&D Systems., Minneapolis, MN #DHYAL0 15-well 3D Ibidi μSlides Ibidi., Fitchburg, WI #81506 Antibodies and stains used: Antibodies/stains Working concentration Vendor Catalog RRID Fluo-4 Assay Kit Calcium 1X Abcam., Cambridge, United Kingdom #ab228555 - Anti-mouse CD44LE/AF KM201 antibody – Functional experiment (i.e., FMD) 0.25mg/mL Southern Biotech., Birmingham Alabama #1500-14 RRID:AB_2794779 IgG1-LE/AF isotype control – Functional experiment (i.e., FMD) 0.25mg/mL Southern Biotech., Birmingham Alabama #0116-14 RRID:AB_2793987 CD44 (MEM-263) 1:100 Abcam., Cambridge, United Kingdom #9524 RRID:AB_307310 Anti-ADAM17 1:100 LSbio., Saratoga, CA #B4426 RRID:AB_10796856 Anti-ADAM17 1:100 Abcam., Cambridge, United Kingdom #39162 RRID:AB_722565 Page 35 of 38 https://mc.manuscriptcentral.com/function Manuscripts submitted to Function 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Downloaded from journals.physiology.org/journal/function (2001:448A:5160:33DE:ADDE:2129:780F:130F) on March 31, 2026. .. For Review Only Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction eNOS/NOS type III 1:100 BD Transduction., Franklin Lakes, NJ #610296 RRID:AB_397690 anti-mouse Alexa Fluor 488 1:300–1:500 Invitrogen., Carlsbad, CA #A21202 RRID:AB_141607 anti-mouse Alexa Fluor 647 1:300–1:500 Invitrogen., Carlsbad, CA #A21235 RRID:AB_2535804 anti-rabbit Alexa Fluor 488 1:300–1:500 Invitrogen., Carlsbad, CA #A32731 RRID:AB_2633280 anti-rabbit Alexa Fluor 647 1:300–1:500 Invitrogen., Carlsbad, CA #A21245 RRID:AB_2535813 40,6-diamidino-2phenylindole (DAPI) 1.5nM; 1:1000 SigmaAldrich, Burlington, MA #D9542 - CD44 (E7K2Y) XP (Western blot) 1:1000 Cell Signaling Technology., Danvers, MA #37259 RRID:AB_2750879 Anti-eNOS (phospho Ser1177) (Western blot) 1:1000 Abcam., Cambridge, United Kingdom #184154 RRID:AB_2768154 eNOS (D9A5L) (Western blot) 1:1000 Cell Signaling Technology., Danvers, MA #32027 RRID:AB_2728756 RP-conjugated Goat Anti-Rabbit 1:5000 Bio-Rad., Hercules, CA #1705046 RRID:AB_11125757 Starbright Blue 700 Anti-Rabbit 1:2000 Bio-Rad., Hercules, CA #12004161 RRID:AB_2721073 Starbright Blue 520 Anti-Mouse 1:2000 Bio-Rad., Hercules, CA #12005866 RRID:AB_2934034 Page 36 of 38 https://mc.manuscriptcentral.com/function Manuscripts submitted to Function 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Downloaded from journals.physiology.org/journal/function (2001:448A:5160:33DE:ADDE:2129:780F:130F) on March 31, 2026.

    Activity Assay:

    Article Title: Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction.
    Article Snippet: For Review Only Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction Supplementary materials and data analyses Reagents and materials used: Reagent/materials Vendor Catalog number Notes Mouse lung dissociation kit Miltenyi Biotec., Bergisch Gladbach, Germany #130-095-927 RIPA Buffer Invitrogen., Carlsbad, CA #1861278 HALTTM phosphatase inhibitor cocktail Invitrogen., Carlsbad, CA #1862495 HUVECs Lonza., Morristown, NJ #CC-2519 ON-TARGETplus SiRNA CD44 (Human) Dharmacon Reagents., Cambridge, United Kingdom #L-009999-000010 LipofectamineTM RNAiMAX transfection reagent Invitrogen., Carlsbad, CA #13778150 Opti-MEMTM medium Gibco., Grand Island, NY #11058021 phorbol 12-myristate 13-acetate Sigma-aldrich., St. Louis, MO #524400 Ad. hADAM17 Vector biolabs., Devault, PA ADV-200349 #2001 Ad-CMV-null Vector biolabs., Devault, PA #1300 Recombinant active ADAM17 R&D Systems., Minneapolis, MN #930-ADB-010 Ibidi μ-Slide VI 0.4 Luer channels Ibidi., Fitchburg, WI #80186 Ibidi μ-Slide I 0.6 Luer channels Ibidi., Fitchburg, WI #80606 Fluo-4 Assay Kit Calcium Abcam., Cambridge, United Kingdom #ab228555 Hyaluronidase from bovine testes Sigma-aldrich., St. Louis, MO #H3506 High-capacity carboxyl sensors Nicoya., Kitchener, Canada #SEN-AU100-10-HC- COOH Page 34 of 38 https://mc.manuscriptcentral.com/function Manuscripts submitted to Function 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Downloaded from journals.physiology.org/journal/function (2001:448A:5160:33DE:ADDE:2129:780F:130F) on March 31, 2026. .. For Review Only Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction Protein A Nicoya., Kitchener, Canada #SEN-AU100-10-PROA- KIT Recombinant human CD44-fc chimera R&D Systems., Minneapolis, MN #3660-CD Hyaluronan Lifecore biomedical., Chaska, MN #HA100K-1 Component C Anaspec., Fremont, CA #AS-72085 SensoLyte TACE activity kit Anaspec., Fremont, CA #AS-72085 Human hyaluronan ELISA kit R&D Systems., Minneapolis, MN #DHYAL0 15-well 3D Ibidi μSlides Ibidi., Fitchburg, WI #81506 Antibodies and stains used: Antibodies/stains Working concentration Vendor Catalog RRID Fluo-4 Assay Kit Calcium 1X Abcam., Cambridge, United Kingdom #ab228555 - Anti-mouse CD44LE/AF KM201 antibody – Functional experiment (i.e., FMD) 0.25mg/mL Southern Biotech., Birmingham Alabama #1500-14 RRID:AB_2794779 IgG1-LE/AF isotype control – Functional experiment (i.e., FMD) 0.25mg/mL Southern Biotech., Birmingham Alabama #0116-14 RRID:AB_2793987 CD44 (MEM-263) 1:100 Abcam., Cambridge, United Kingdom #9524 RRID:AB_307310 Anti-ADAM17 1:100 LSbio., Saratoga, CA #B4426 RRID:AB_10796856 Anti-ADAM17 1:100 Abcam., Cambridge, United Kingdom #39162 RRID:AB_722565 Page 35 of 38 https://mc.manuscriptcentral.com/function Manuscripts submitted to Function 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Downloaded from journals.physiology.org/journal/function (2001:448A:5160:33DE:ADDE:2129:780F:130F) on March 31, 2026. .. For Review Only Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction eNOS/NOS type III 1:100 BD Transduction., Franklin Lakes, NJ #610296 RRID:AB_397690 anti-mouse Alexa Fluor 488 1:300–1:500 Invitrogen., Carlsbad, CA #A21202 RRID:AB_141607 anti-mouse Alexa Fluor 647 1:300–1:500 Invitrogen., Carlsbad, CA #A21235 RRID:AB_2535804 anti-rabbit Alexa Fluor 488 1:300–1:500 Invitrogen., Carlsbad, CA #A32731 RRID:AB_2633280 anti-rabbit Alexa Fluor 647 1:300–1:500 Invitrogen., Carlsbad, CA #A21245 RRID:AB_2535813 40,6-diamidino-2phenylindole (DAPI) 1.5nM; 1:1000 SigmaAldrich, Burlington, MA #D9542 - CD44 (E7K2Y) XP (Western blot) 1:1000 Cell Signaling Technology., Danvers, MA #37259 RRID:AB_2750879 Anti-eNOS (phospho Ser1177) (Western blot) 1:1000 Abcam., Cambridge, United Kingdom #184154 RRID:AB_2768154 eNOS (D9A5L) (Western blot) 1:1000 Cell Signaling Technology., Danvers, MA #32027 RRID:AB_2728756 RP-conjugated Goat Anti-Rabbit 1:5000 Bio-Rad., Hercules, CA #1705046 RRID:AB_11125757 Starbright Blue 700 Anti-Rabbit 1:2000 Bio-Rad., Hercules, CA #12004161 RRID:AB_2721073 Starbright Blue 520 Anti-Mouse 1:2000 Bio-Rad., Hercules, CA #12005866 RRID:AB_2934034 Page 36 of 38 https://mc.manuscriptcentral.com/function Manuscripts submitted to Function 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Downloaded from journals.physiology.org/journal/function (2001:448A:5160:33DE:ADDE:2129:780F:130F) on March 31, 2026.

    Enzyme-linked Immunosorbent Assay:

    Article Title: Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction.
    Article Snippet: For Review Only Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction Supplementary materials and data analyses Reagents and materials used: Reagent/materials Vendor Catalog number Notes Mouse lung dissociation kit Miltenyi Biotec., Bergisch Gladbach, Germany #130-095-927 RIPA Buffer Invitrogen., Carlsbad, CA #1861278 HALTTM phosphatase inhibitor cocktail Invitrogen., Carlsbad, CA #1862495 HUVECs Lonza., Morristown, NJ #CC-2519 ON-TARGETplus SiRNA CD44 (Human) Dharmacon Reagents., Cambridge, United Kingdom #L-009999-000010 LipofectamineTM RNAiMAX transfection reagent Invitrogen., Carlsbad, CA #13778150 Opti-MEMTM medium Gibco., Grand Island, NY #11058021 phorbol 12-myristate 13-acetate Sigma-aldrich., St. Louis, MO #524400 Ad. hADAM17 Vector biolabs., Devault, PA ADV-200349 #2001 Ad-CMV-null Vector biolabs., Devault, PA #1300 Recombinant active ADAM17 R&D Systems., Minneapolis, MN #930-ADB-010 Ibidi μ-Slide VI 0.4 Luer channels Ibidi., Fitchburg, WI #80186 Ibidi μ-Slide I 0.6 Luer channels Ibidi., Fitchburg, WI #80606 Fluo-4 Assay Kit Calcium Abcam., Cambridge, United Kingdom #ab228555 Hyaluronidase from bovine testes Sigma-aldrich., St. Louis, MO #H3506 High-capacity carboxyl sensors Nicoya., Kitchener, Canada #SEN-AU100-10-HC- COOH Page 34 of 38 https://mc.manuscriptcentral.com/function Manuscripts submitted to Function 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Downloaded from journals.physiology.org/journal/function (2001:448A:5160:33DE:ADDE:2129:780F:130F) on March 31, 2026. .. For Review Only Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction Protein A Nicoya., Kitchener, Canada #SEN-AU100-10-PROA- KIT Recombinant human CD44-fc chimera R&D Systems., Minneapolis, MN #3660-CD Hyaluronan Lifecore biomedical., Chaska, MN #HA100K-1 Component C Anaspec., Fremont, CA #AS-72085 SensoLyte TACE activity kit Anaspec., Fremont, CA #AS-72085 Human hyaluronan ELISA kit R&D Systems., Minneapolis, MN #DHYAL0 15-well 3D Ibidi μSlides Ibidi., Fitchburg, WI #81506 Antibodies and stains used: Antibodies/stains Working concentration Vendor Catalog RRID Fluo-4 Assay Kit Calcium 1X Abcam., Cambridge, United Kingdom #ab228555 - Anti-mouse CD44LE/AF KM201 antibody – Functional experiment (i.e., FMD) 0.25mg/mL Southern Biotech., Birmingham Alabama #1500-14 RRID:AB_2794779 IgG1-LE/AF isotype control – Functional experiment (i.e., FMD) 0.25mg/mL Southern Biotech., Birmingham Alabama #0116-14 RRID:AB_2793987 CD44 (MEM-263) 1:100 Abcam., Cambridge, United Kingdom #9524 RRID:AB_307310 Anti-ADAM17 1:100 LSbio., Saratoga, CA #B4426 RRID:AB_10796856 Anti-ADAM17 1:100 Abcam., Cambridge, United Kingdom #39162 RRID:AB_722565 Page 35 of 38 https://mc.manuscriptcentral.com/function Manuscripts submitted to Function 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Downloaded from journals.physiology.org/journal/function (2001:448A:5160:33DE:ADDE:2129:780F:130F) on March 31, 2026. .. For Review Only Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction eNOS/NOS type III 1:100 BD Transduction., Franklin Lakes, NJ #610296 RRID:AB_397690 anti-mouse Alexa Fluor 488 1:300–1:500 Invitrogen., Carlsbad, CA #A21202 RRID:AB_141607 anti-mouse Alexa Fluor 647 1:300–1:500 Invitrogen., Carlsbad, CA #A21235 RRID:AB_2535804 anti-rabbit Alexa Fluor 488 1:300–1:500 Invitrogen., Carlsbad, CA #A32731 RRID:AB_2633280 anti-rabbit Alexa Fluor 647 1:300–1:500 Invitrogen., Carlsbad, CA #A21245 RRID:AB_2535813 40,6-diamidino-2phenylindole (DAPI) 1.5nM; 1:1000 SigmaAldrich, Burlington, MA #D9542 - CD44 (E7K2Y) XP (Western blot) 1:1000 Cell Signaling Technology., Danvers, MA #37259 RRID:AB_2750879 Anti-eNOS (phospho Ser1177) (Western blot) 1:1000 Abcam., Cambridge, United Kingdom #184154 RRID:AB_2768154 eNOS (D9A5L) (Western blot) 1:1000 Cell Signaling Technology., Danvers, MA #32027 RRID:AB_2728756 RP-conjugated Goat Anti-Rabbit 1:5000 Bio-Rad., Hercules, CA #1705046 RRID:AB_11125757 Starbright Blue 700 Anti-Rabbit 1:2000 Bio-Rad., Hercules, CA #12004161 RRID:AB_2721073 Starbright Blue 520 Anti-Mouse 1:2000 Bio-Rad., Hercules, CA #12005866 RRID:AB_2934034 Page 36 of 38 https://mc.manuscriptcentral.com/function Manuscripts submitted to Function 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Downloaded from journals.physiology.org/journal/function (2001:448A:5160:33DE:ADDE:2129:780F:130F) on March 31, 2026.

    Concentration Assay:

    Article Title: Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction.
    Article Snippet: For Review Only Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction Supplementary materials and data analyses Reagents and materials used: Reagent/materials Vendor Catalog number Notes Mouse lung dissociation kit Miltenyi Biotec., Bergisch Gladbach, Germany #130-095-927 RIPA Buffer Invitrogen., Carlsbad, CA #1861278 HALTTM phosphatase inhibitor cocktail Invitrogen., Carlsbad, CA #1862495 HUVECs Lonza., Morristown, NJ #CC-2519 ON-TARGETplus SiRNA CD44 (Human) Dharmacon Reagents., Cambridge, United Kingdom #L-009999-000010 LipofectamineTM RNAiMAX transfection reagent Invitrogen., Carlsbad, CA #13778150 Opti-MEMTM medium Gibco., Grand Island, NY #11058021 phorbol 12-myristate 13-acetate Sigma-aldrich., St. Louis, MO #524400 Ad. hADAM17 Vector biolabs., Devault, PA ADV-200349 #2001 Ad-CMV-null Vector biolabs., Devault, PA #1300 Recombinant active ADAM17 R&D Systems., Minneapolis, MN #930-ADB-010 Ibidi μ-Slide VI 0.4 Luer channels Ibidi., Fitchburg, WI #80186 Ibidi μ-Slide I 0.6 Luer channels Ibidi., Fitchburg, WI #80606 Fluo-4 Assay Kit Calcium Abcam., Cambridge, United Kingdom #ab228555 Hyaluronidase from bovine testes Sigma-aldrich., St. Louis, MO #H3506 High-capacity carboxyl sensors Nicoya., Kitchener, Canada #SEN-AU100-10-HC- COOH Page 34 of 38 https://mc.manuscriptcentral.com/function Manuscripts submitted to Function 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Downloaded from journals.physiology.org/journal/function (2001:448A:5160:33DE:ADDE:2129:780F:130F) on March 31, 2026. .. For Review Only Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction Protein A Nicoya., Kitchener, Canada #SEN-AU100-10-PROA- KIT Recombinant human CD44-fc chimera R&D Systems., Minneapolis, MN #3660-CD Hyaluronan Lifecore biomedical., Chaska, MN #HA100K-1 Component C Anaspec., Fremont, CA #AS-72085 SensoLyte TACE activity kit Anaspec., Fremont, CA #AS-72085 Human hyaluronan ELISA kit R&D Systems., Minneapolis, MN #DHYAL0 15-well 3D Ibidi μSlides Ibidi., Fitchburg, WI #81506 Antibodies and stains used: Antibodies/stains Working concentration Vendor Catalog RRID Fluo-4 Assay Kit Calcium 1X Abcam., Cambridge, United Kingdom #ab228555 - Anti-mouse CD44LE/AF KM201 antibody – Functional experiment (i.e., FMD) 0.25mg/mL Southern Biotech., Birmingham Alabama #1500-14 RRID:AB_2794779 IgG1-LE/AF isotype control – Functional experiment (i.e., FMD) 0.25mg/mL Southern Biotech., Birmingham Alabama #0116-14 RRID:AB_2793987 CD44 (MEM-263) 1:100 Abcam., Cambridge, United Kingdom #9524 RRID:AB_307310 Anti-ADAM17 1:100 LSbio., Saratoga, CA #B4426 RRID:AB_10796856 Anti-ADAM17 1:100 Abcam., Cambridge, United Kingdom #39162 RRID:AB_722565 Page 35 of 38 https://mc.manuscriptcentral.com/function Manuscripts submitted to Function 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Downloaded from journals.physiology.org/journal/function (2001:448A:5160:33DE:ADDE:2129:780F:130F) on March 31, 2026. .. For Review Only Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction eNOS/NOS type III 1:100 BD Transduction., Franklin Lakes, NJ #610296 RRID:AB_397690 anti-mouse Alexa Fluor 488 1:300–1:500 Invitrogen., Carlsbad, CA #A21202 RRID:AB_141607 anti-mouse Alexa Fluor 647 1:300–1:500 Invitrogen., Carlsbad, CA #A21235 RRID:AB_2535804 anti-rabbit Alexa Fluor 488 1:300–1:500 Invitrogen., Carlsbad, CA #A32731 RRID:AB_2633280 anti-rabbit Alexa Fluor 647 1:300–1:500 Invitrogen., Carlsbad, CA #A21245 RRID:AB_2535813 40,6-diamidino-2phenylindole (DAPI) 1.5nM; 1:1000 SigmaAldrich, Burlington, MA #D9542 - CD44 (E7K2Y) XP (Western blot) 1:1000 Cell Signaling Technology., Danvers, MA #37259 RRID:AB_2750879 Anti-eNOS (phospho Ser1177) (Western blot) 1:1000 Abcam., Cambridge, United Kingdom #184154 RRID:AB_2768154 eNOS (D9A5L) (Western blot) 1:1000 Cell Signaling Technology., Danvers, MA #32027 RRID:AB_2728756 RP-conjugated Goat Anti-Rabbit 1:5000 Bio-Rad., Hercules, CA #1705046 RRID:AB_11125757 Starbright Blue 700 Anti-Rabbit 1:2000 Bio-Rad., Hercules, CA #12004161 RRID:AB_2721073 Starbright Blue 520 Anti-Mouse 1:2000 Bio-Rad., Hercules, CA #12005866 RRID:AB_2934034 Page 36 of 38 https://mc.manuscriptcentral.com/function Manuscripts submitted to Function 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Downloaded from journals.physiology.org/journal/function (2001:448A:5160:33DE:ADDE:2129:780F:130F) on March 31, 2026.

    Functional Assay:

    Article Title: Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction.
    Article Snippet: For Review Only Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction Supplementary materials and data analyses Reagents and materials used: Reagent/materials Vendor Catalog number Notes Mouse lung dissociation kit Miltenyi Biotec., Bergisch Gladbach, Germany #130-095-927 RIPA Buffer Invitrogen., Carlsbad, CA #1861278 HALTTM phosphatase inhibitor cocktail Invitrogen., Carlsbad, CA #1862495 HUVECs Lonza., Morristown, NJ #CC-2519 ON-TARGETplus SiRNA CD44 (Human) Dharmacon Reagents., Cambridge, United Kingdom #L-009999-000010 LipofectamineTM RNAiMAX transfection reagent Invitrogen., Carlsbad, CA #13778150 Opti-MEMTM medium Gibco., Grand Island, NY #11058021 phorbol 12-myristate 13-acetate Sigma-aldrich., St. Louis, MO #524400 Ad. hADAM17 Vector biolabs., Devault, PA ADV-200349 #2001 Ad-CMV-null Vector biolabs., Devault, PA #1300 Recombinant active ADAM17 R&D Systems., Minneapolis, MN #930-ADB-010 Ibidi μ-Slide VI 0.4 Luer channels Ibidi., Fitchburg, WI #80186 Ibidi μ-Slide I 0.6 Luer channels Ibidi., Fitchburg, WI #80606 Fluo-4 Assay Kit Calcium Abcam., Cambridge, United Kingdom #ab228555 Hyaluronidase from bovine testes Sigma-aldrich., St. Louis, MO #H3506 High-capacity carboxyl sensors Nicoya., Kitchener, Canada #SEN-AU100-10-HC- COOH Page 34 of 38 https://mc.manuscriptcentral.com/function Manuscripts submitted to Function 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Downloaded from journals.physiology.org/journal/function (2001:448A:5160:33DE:ADDE:2129:780F:130F) on March 31, 2026. .. For Review Only Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction Protein A Nicoya., Kitchener, Canada #SEN-AU100-10-PROA- KIT Recombinant human CD44-fc chimera R&D Systems., Minneapolis, MN #3660-CD Hyaluronan Lifecore biomedical., Chaska, MN #HA100K-1 Component C Anaspec., Fremont, CA #AS-72085 SensoLyte TACE activity kit Anaspec., Fremont, CA #AS-72085 Human hyaluronan ELISA kit R&D Systems., Minneapolis, MN #DHYAL0 15-well 3D Ibidi μSlides Ibidi., Fitchburg, WI #81506 Antibodies and stains used: Antibodies/stains Working concentration Vendor Catalog RRID Fluo-4 Assay Kit Calcium 1X Abcam., Cambridge, United Kingdom #ab228555 - Anti-mouse CD44LE/AF KM201 antibody – Functional experiment (i.e., FMD) 0.25mg/mL Southern Biotech., Birmingham Alabama #1500-14 RRID:AB_2794779 IgG1-LE/AF isotype control – Functional experiment (i.e., FMD) 0.25mg/mL Southern Biotech., Birmingham Alabama #0116-14 RRID:AB_2793987 CD44 (MEM-263) 1:100 Abcam., Cambridge, United Kingdom #9524 RRID:AB_307310 Anti-ADAM17 1:100 LSbio., Saratoga, CA #B4426 RRID:AB_10796856 Anti-ADAM17 1:100 Abcam., Cambridge, United Kingdom #39162 RRID:AB_722565 Page 35 of 38 https://mc.manuscriptcentral.com/function Manuscripts submitted to Function 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Downloaded from journals.physiology.org/journal/function (2001:448A:5160:33DE:ADDE:2129:780F:130F) on March 31, 2026. .. For Review Only Endothelial CD44 cleavage by ADAM17 impairs shear stress mechanotransduction eNOS/NOS type III 1:100 BD Transduction., Franklin Lakes, NJ #610296 RRID:AB_397690 anti-mouse Alexa Fluor 488 1:300–1:500 Invitrogen., Carlsbad, CA #A21202 RRID:AB_141607 anti-mouse Alexa Fluor 647 1:300–1:500 Invitrogen., Carlsbad, CA #A21235 RRID:AB_2535804 anti-rabbit Alexa Fluor 488 1:300–1:500 Invitrogen., Carlsbad, CA #A32731 RRID:AB_2633280 anti-rabbit Alexa Fluor 647 1:300–1:500 Invitrogen., Carlsbad, CA #A21245 RRID:AB_2535813 40,6-diamidino-2phenylindole (DAPI) 1.5nM; 1:1000 SigmaAldrich, Burlington, MA #D9542 - CD44 (E7K2Y) XP (Western blot) 1:1000 Cell Signaling Technology., Danvers, MA #37259 RRID:AB_2750879 Anti-eNOS (phospho Ser1177) (Western blot) 1:1000 Abcam., Cambridge, United Kingdom #184154 RRID:AB_2768154 eNOS (D9A5L) (Western blot) 1:1000 Cell Signaling Technology., Danvers, MA #32027 RRID:AB_2728756 RP-conjugated Goat Anti-Rabbit 1:5000 Bio-Rad., Hercules, CA #1705046 RRID:AB_11125757 Starbright Blue 700 Anti-Rabbit 1:2000 Bio-Rad., Hercules, CA #12004161 RRID:AB_2721073 Starbright Blue 520 Anti-Mouse 1:2000 Bio-Rad., Hercules, CA #12005866 RRID:AB_2934034 Page 36 of 38 https://mc.manuscriptcentral.com/function Manuscripts submitted to Function 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 Downloaded from journals.physiology.org/journal/function (2001:448A:5160:33DE:ADDE:2129:780F:130F) on March 31, 2026.

    Purification:

    Article Title: The protease cathepsin K can debulk the cancer glycocalyx
    Article Snippet: A minimum of 20,000 live, single cells up to 180 μl of sample were analyzed using a MACSQuant Analyzer 10 flow cytometer (Miltenyi Biotec). .. Recombinant PSGL-1 (10 μg; Sino Biological; 13863-H08H), recombinant MUC1 (Sino Biological; 12123-H05H), recombinant CD43 (R&D Systems; 9680-CD-050), fetuin (Promega; V4961), and purified MUC16 (purified from OVCAR-3 as above) were mixed with CTSK or PBS control at a 1:50 CTSK:substrate molar ratio in 1:1 PBS:100 mM sodium acetate with a final pH of 5 (buffer pHed as above). ..

    Sequencing:

    Article Title: Bispecific nanoparticle systems for targeting cancer cells
    Article Snippet: .. Cat. No. Immunogen Anti-CD3 CD3 antibody | CD3- Bio-Rad MCA1477 Synthetic peptide 12 sequence derived from cytoplasmic epitope of CD3 (Glu- Arg-Pro-Pro-Pro-Val- Pro-Asn-Pro-Asp-Tyr- Glu-Pro-Cys) Anti-HEr2 Herceptin ® Genentech 440 mg vial — (Trastuzumab) 440 mg CD19 Recombinant Human R&D systems 9269-CD-050 — CD19 Fc Chimera Protein, CF CAR-T cell CD19 scFv-CD22 Promab PM-CAR1050- — scFv-4-1BB-CD3- 1M T2A-RQR8 (Ritiximab suicide switch) .. Cell Lines and Cell Culture Media PC3, SKBR3, and HUVEC cells were obtained from Innoprot.

    Derivative Assay:

    Article Title: Bispecific nanoparticle systems for targeting cancer cells
    Article Snippet: .. Cat. No. Immunogen Anti-CD3 CD3 antibody | CD3- Bio-Rad MCA1477 Synthetic peptide 12 sequence derived from cytoplasmic epitope of CD3 (Glu- Arg-Pro-Pro-Pro-Val- Pro-Asn-Pro-Asp-Tyr- Glu-Pro-Cys) Anti-HEr2 Herceptin ® Genentech 440 mg vial — (Trastuzumab) 440 mg CD19 Recombinant Human R&D systems 9269-CD-050 — CD19 Fc Chimera Protein, CF CAR-T cell CD19 scFv-CD22 Promab PM-CAR1050- — scFv-4-1BB-CD3- 1M T2A-RQR8 (Ritiximab suicide switch) .. Cell Lines and Cell Culture Media PC3, SKBR3, and HUVEC cells were obtained from Innoprot.



    Similar Products

    94
    Streck Laboratories cd chex plus stabilized human blood
    Comparison of PaCMAP-based and traditional 2D biaxial gating consistency for leukocyte subset identification. <t>CD-CHEX–stabilised</t> blood from two donors (different lots; CD1 and CD2) was gated across up to four experimental timepoints by three independent expert operators using either traditional 2D hierarchical biaxial gating (purple) or PaCMAP dimensionality-reduction-based gating (green). Gating purity was assessed against UMAP-defined reference gates drawn by a single expert. (A) Longitudinal trajectories of correct-assignment percentages (% cells landing in the corresponding UMAP reference gate) across timepoints (Vo1 to Vo4), faceted by population (columns); the two donors are distinguished within each facet by point shape (circle, triangle) and mean-line style (solid, long-dashed). Each bold line links the per-donor mean at each timepoint (filled points, colored by method); dotted light lines are individual operator trajectories (largely overlapping and difficult to discern for PaCMAP). The y-axis is pseudo-log-scaled to resolve values near 100% (using scales::pseudo_log_trans(sigma = 0.1) in R). (B) Boxplots of correct-assignment percentages per population; boxes show the interquartile range (IQR), whiskers extend to 1.5 × IQR, white diamonds mark the group mean, and dots are individual operator × timepoint observations, colored by method and shaped by donor. (C) Boxplots of contamination percentages (% cells from a gated population landing in a non-corresponding UMAP reference gate) faceted by UMAP gated population, on a pseudo-log axis to accommodate the many zero values; boxes and dots as in (B) , with donor shown by point shape. (D) Summary of Wilcoxon rank-sum comparisons (Benjamini–Hochberg-adjusted) between methods across six metrics: correct-assignment temporal stability (SD), correct-assignment inter-rater ICC, mean contamination, proportion of zero-contamination events, contamination temporal stability (SD) and contamination inter-rater ICC; columns give each method’s group mean, the adjusted p-value and the direction; cell color indicates the significant direction (green, PaCMAP superior; orange, 2D superior; white, p ≥ 0.05). ICC (intraclass correlation coefficient) was computed with a two-way model, absolute agreement, single unit (irr::icc); groups with undefined between-operator variance were excluded as degenerate (fewer than two timepoints or three raters, or near-zero overall variance [SD < 0.01]; groups with identical values across raters were treated as perfect agreement), leaving n = 15 (PaCMAP) and n = 16 (2D) for correct assignment. Temporal-stability SD, mean contamination and the zero-contamination proportion were computed per operator and then compared between methods, isolating within-operator consistency; ICC uses the three operators as raters and therefore quantifies between-operator agreement.
    Cd Chex Plus Stabilized Human Blood, supplied by Streck Laboratories, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd/CD-Chex+Plus/pmc13677906-47-0-12
    Average 94 stars, based on 1 article reviews
    cd chex plus stabilized human blood - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    MedChemExpress usp7 cd
    Comparison of PaCMAP-based and traditional 2D biaxial gating consistency for leukocyte subset identification. <t>CD-CHEX–stabilised</t> blood from two donors (different lots; CD1 and CD2) was gated across up to four experimental timepoints by three independent expert operators using either traditional 2D hierarchical biaxial gating (purple) or PaCMAP dimensionality-reduction-based gating (green). Gating purity was assessed against UMAP-defined reference gates drawn by a single expert. (A) Longitudinal trajectories of correct-assignment percentages (% cells landing in the corresponding UMAP reference gate) across timepoints (Vo1 to Vo4), faceted by population (columns); the two donors are distinguished within each facet by point shape (circle, triangle) and mean-line style (solid, long-dashed). Each bold line links the per-donor mean at each timepoint (filled points, colored by method); dotted light lines are individual operator trajectories (largely overlapping and difficult to discern for PaCMAP). The y-axis is pseudo-log-scaled to resolve values near 100% (using scales::pseudo_log_trans(sigma = 0.1) in R). (B) Boxplots of correct-assignment percentages per population; boxes show the interquartile range (IQR), whiskers extend to 1.5 × IQR, white diamonds mark the group mean, and dots are individual operator × timepoint observations, colored by method and shaped by donor. (C) Boxplots of contamination percentages (% cells from a gated population landing in a non-corresponding UMAP reference gate) faceted by UMAP gated population, on a pseudo-log axis to accommodate the many zero values; boxes and dots as in (B) , with donor shown by point shape. (D) Summary of Wilcoxon rank-sum comparisons (Benjamini–Hochberg-adjusted) between methods across six metrics: correct-assignment temporal stability (SD), correct-assignment inter-rater ICC, mean contamination, proportion of zero-contamination events, contamination temporal stability (SD) and contamination inter-rater ICC; columns give each method’s group mean, the adjusted p-value and the direction; cell color indicates the significant direction (green, PaCMAP superior; orange, 2D superior; white, p ≥ 0.05). ICC (intraclass correlation coefficient) was computed with a two-way model, absolute agreement, single unit (irr::icc); groups with undefined between-operator variance were excluded as degenerate (fewer than two timepoints or three raters, or near-zero overall variance [SD < 0.01]; groups with identical values across raters were treated as perfect agreement), leaving n = 15 (PaCMAP) and n = 16 (2D) for correct assignment. Temporal-stability SD, mean contamination and the zero-contamination proportion were computed per operator and then compared between methods, isolating within-operator consistency; ICC uses the three operators as raters and therefore quantifies between-operator agreement.
    Usp7 Cd, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd/USP7%2C+Human/10__3390_slash_ph19081219-305-19-20
    Average 94 stars, based on 1 article reviews
    usp7 cd - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    R&D Systems differentiation 36
    Comparison of PaCMAP-based and traditional 2D biaxial gating consistency for leukocyte subset identification. <t>CD-CHEX–stabilised</t> blood from two donors (different lots; CD1 and CD2) was gated across up to four experimental timepoints by three independent expert operators using either traditional 2D hierarchical biaxial gating (purple) or PaCMAP dimensionality-reduction-based gating (green). Gating purity was assessed against UMAP-defined reference gates drawn by a single expert. (A) Longitudinal trajectories of correct-assignment percentages (% cells landing in the corresponding UMAP reference gate) across timepoints (Vo1 to Vo4), faceted by population (columns); the two donors are distinguished within each facet by point shape (circle, triangle) and mean-line style (solid, long-dashed). Each bold line links the per-donor mean at each timepoint (filled points, colored by method); dotted light lines are individual operator trajectories (largely overlapping and difficult to discern for PaCMAP). The y-axis is pseudo-log-scaled to resolve values near 100% (using scales::pseudo_log_trans(sigma = 0.1) in R). (B) Boxplots of correct-assignment percentages per population; boxes show the interquartile range (IQR), whiskers extend to 1.5 × IQR, white diamonds mark the group mean, and dots are individual operator × timepoint observations, colored by method and shaped by donor. (C) Boxplots of contamination percentages (% cells from a gated population landing in a non-corresponding UMAP reference gate) faceted by UMAP gated population, on a pseudo-log axis to accommodate the many zero values; boxes and dots as in (B) , with donor shown by point shape. (D) Summary of Wilcoxon rank-sum comparisons (Benjamini–Hochberg-adjusted) between methods across six metrics: correct-assignment temporal stability (SD), correct-assignment inter-rater ICC, mean contamination, proportion of zero-contamination events, contamination temporal stability (SD) and contamination inter-rater ICC; columns give each method’s group mean, the adjusted p-value and the direction; cell color indicates the significant direction (green, PaCMAP superior; orange, 2D superior; white, p ≥ 0.05). ICC (intraclass correlation coefficient) was computed with a two-way model, absolute agreement, single unit (irr::icc); groups with undefined between-operator variance were excluded as degenerate (fewer than two timepoints or three raters, or near-zero overall variance [SD < 0.01]; groups with identical values across raters were treated as perfect agreement), leaving n = 15 (PaCMAP) and n = 16 (2D) for correct assignment. Temporal-stability SD, mean contamination and the zero-contamination proportion were computed per operator and then compared between methods, isolating within-operator consistency; ICC uses the three operators as raters and therefore quantifies between-operator agreement.
    Differentiation 36, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd/Recombinant+Human+CD36%2FSR-B3+Fc+Chimera+Protein%2C+CF/pmc13064270-68-11-24
    Average 94 stars, based on 1 article reviews
    differentiation 36 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    R&D Systems au100 10 proa kit recombinant human cd44 fc chimera r d systems
    Comparison of PaCMAP-based and traditional 2D biaxial gating consistency for leukocyte subset identification. <t>CD-CHEX–stabilised</t> blood from two donors (different lots; CD1 and CD2) was gated across up to four experimental timepoints by three independent expert operators using either traditional 2D hierarchical biaxial gating (purple) or PaCMAP dimensionality-reduction-based gating (green). Gating purity was assessed against UMAP-defined reference gates drawn by a single expert. (A) Longitudinal trajectories of correct-assignment percentages (% cells landing in the corresponding UMAP reference gate) across timepoints (Vo1 to Vo4), faceted by population (columns); the two donors are distinguished within each facet by point shape (circle, triangle) and mean-line style (solid, long-dashed). Each bold line links the per-donor mean at each timepoint (filled points, colored by method); dotted light lines are individual operator trajectories (largely overlapping and difficult to discern for PaCMAP). The y-axis is pseudo-log-scaled to resolve values near 100% (using scales::pseudo_log_trans(sigma = 0.1) in R). (B) Boxplots of correct-assignment percentages per population; boxes show the interquartile range (IQR), whiskers extend to 1.5 × IQR, white diamonds mark the group mean, and dots are individual operator × timepoint observations, colored by method and shaped by donor. (C) Boxplots of contamination percentages (% cells from a gated population landing in a non-corresponding UMAP reference gate) faceted by UMAP gated population, on a pseudo-log axis to accommodate the many zero values; boxes and dots as in (B) , with donor shown by point shape. (D) Summary of Wilcoxon rank-sum comparisons (Benjamini–Hochberg-adjusted) between methods across six metrics: correct-assignment temporal stability (SD), correct-assignment inter-rater ICC, mean contamination, proportion of zero-contamination events, contamination temporal stability (SD) and contamination inter-rater ICC; columns give each method’s group mean, the adjusted p-value and the direction; cell color indicates the significant direction (green, PaCMAP superior; orange, 2D superior; white, p ≥ 0.05). ICC (intraclass correlation coefficient) was computed with a two-way model, absolute agreement, single unit (irr::icc); groups with undefined between-operator variance were excluded as degenerate (fewer than two timepoints or three raters, or near-zero overall variance [SD < 0.01]; groups with identical values across raters were treated as perfect agreement), leaving n = 15 (PaCMAP) and n = 16 (2D) for correct assignment. Temporal-stability SD, mean contamination and the zero-contamination proportion were computed per operator and then compared between methods, isolating within-operator consistency; ICC uses the three operators as raters and therefore quantifies between-operator agreement.
    Au100 10 Proa Kit Recombinant Human Cd44 Fc Chimera R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd/Recombinant+Human+CD44+Fc+Chimera+Protein%2C+CF/pm41871316-478-17-23
    Average 94 stars, based on 1 article reviews
    au100 10 proa kit recombinant human cd44 fc chimera r d systems - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    R&D Systems recombinant human cd44 fc chimera
    Comparison of PaCMAP-based and traditional 2D biaxial gating consistency for leukocyte subset identification. <t>CD-CHEX–stabilised</t> blood from two donors (different lots; CD1 and CD2) was gated across up to four experimental timepoints by three independent expert operators using either traditional 2D hierarchical biaxial gating (purple) or PaCMAP dimensionality-reduction-based gating (green). Gating purity was assessed against UMAP-defined reference gates drawn by a single expert. (A) Longitudinal trajectories of correct-assignment percentages (% cells landing in the corresponding UMAP reference gate) across timepoints (Vo1 to Vo4), faceted by population (columns); the two donors are distinguished within each facet by point shape (circle, triangle) and mean-line style (solid, long-dashed). Each bold line links the per-donor mean at each timepoint (filled points, colored by method); dotted light lines are individual operator trajectories (largely overlapping and difficult to discern for PaCMAP). The y-axis is pseudo-log-scaled to resolve values near 100% (using scales::pseudo_log_trans(sigma = 0.1) in R). (B) Boxplots of correct-assignment percentages per population; boxes show the interquartile range (IQR), whiskers extend to 1.5 × IQR, white diamonds mark the group mean, and dots are individual operator × timepoint observations, colored by method and shaped by donor. (C) Boxplots of contamination percentages (% cells from a gated population landing in a non-corresponding UMAP reference gate) faceted by UMAP gated population, on a pseudo-log axis to accommodate the many zero values; boxes and dots as in (B) , with donor shown by point shape. (D) Summary of Wilcoxon rank-sum comparisons (Benjamini–Hochberg-adjusted) between methods across six metrics: correct-assignment temporal stability (SD), correct-assignment inter-rater ICC, mean contamination, proportion of zero-contamination events, contamination temporal stability (SD) and contamination inter-rater ICC; columns give each method’s group mean, the adjusted p-value and the direction; cell color indicates the significant direction (green, PaCMAP superior; orange, 2D superior; white, p ≥ 0.05). ICC (intraclass correlation coefficient) was computed with a two-way model, absolute agreement, single unit (irr::icc); groups with undefined between-operator variance were excluded as degenerate (fewer than two timepoints or three raters, or near-zero overall variance [SD < 0.01]; groups with identical values across raters were treated as perfect agreement), leaving n = 15 (PaCMAP) and n = 16 (2D) for correct assignment. Temporal-stability SD, mean contamination and the zero-contamination proportion were computed per operator and then compared between methods, isolating within-operator consistency; ICC uses the three operators as raters and therefore quantifies between-operator agreement.
    Recombinant Human Cd44 Fc Chimera, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd/Recombinant+Human+CD44+Fc+Chimera+Protein%2C+CF/pm41871316-93-26-32
    Average 94 stars, based on 1 article reviews
    recombinant human cd44 fc chimera - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    R&D Systems cd19 recombinant human r d systems 9269 cd
    Comparison of PaCMAP-based and traditional 2D biaxial gating consistency for leukocyte subset identification. <t>CD-CHEX–stabilised</t> blood from two donors (different lots; CD1 and CD2) was gated across up to four experimental timepoints by three independent expert operators using either traditional 2D hierarchical biaxial gating (purple) or PaCMAP dimensionality-reduction-based gating (green). Gating purity was assessed against UMAP-defined reference gates drawn by a single expert. (A) Longitudinal trajectories of correct-assignment percentages (% cells landing in the corresponding UMAP reference gate) across timepoints (Vo1 to Vo4), faceted by population (columns); the two donors are distinguished within each facet by point shape (circle, triangle) and mean-line style (solid, long-dashed). Each bold line links the per-donor mean at each timepoint (filled points, colored by method); dotted light lines are individual operator trajectories (largely overlapping and difficult to discern for PaCMAP). The y-axis is pseudo-log-scaled to resolve values near 100% (using scales::pseudo_log_trans(sigma = 0.1) in R). (B) Boxplots of correct-assignment percentages per population; boxes show the interquartile range (IQR), whiskers extend to 1.5 × IQR, white diamonds mark the group mean, and dots are individual operator × timepoint observations, colored by method and shaped by donor. (C) Boxplots of contamination percentages (% cells from a gated population landing in a non-corresponding UMAP reference gate) faceted by UMAP gated population, on a pseudo-log axis to accommodate the many zero values; boxes and dots as in (B) , with donor shown by point shape. (D) Summary of Wilcoxon rank-sum comparisons (Benjamini–Hochberg-adjusted) between methods across six metrics: correct-assignment temporal stability (SD), correct-assignment inter-rater ICC, mean contamination, proportion of zero-contamination events, contamination temporal stability (SD) and contamination inter-rater ICC; columns give each method’s group mean, the adjusted p-value and the direction; cell color indicates the significant direction (green, PaCMAP superior; orange, 2D superior; white, p ≥ 0.05). ICC (intraclass correlation coefficient) was computed with a two-way model, absolute agreement, single unit (irr::icc); groups with undefined between-operator variance were excluded as degenerate (fewer than two timepoints or three raters, or near-zero overall variance [SD < 0.01]; groups with identical values across raters were treated as perfect agreement), leaving n = 15 (PaCMAP) and n = 16 (2D) for correct assignment. Temporal-stability SD, mean contamination and the zero-contamination proportion were computed per operator and then compared between methods, isolating within-operator consistency; ICC uses the three operators as raters and therefore quantifies between-operator agreement.
    Cd19 Recombinant Human R D Systems 9269 Cd, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd/Recombinant+Human+CD19+Fc+Chimera+Protein%2C+CF/us12576160-565-35-38
    Average 94 stars, based on 1 article reviews
    cd19 recombinant human r d systems 9269 cd - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    95
    TaKaRa human ankrd49 coding sequence cds
    Comparison of PaCMAP-based and traditional 2D biaxial gating consistency for leukocyte subset identification. <t>CD-CHEX–stabilised</t> blood from two donors (different lots; CD1 and CD2) was gated across up to four experimental timepoints by three independent expert operators using either traditional 2D hierarchical biaxial gating (purple) or PaCMAP dimensionality-reduction-based gating (green). Gating purity was assessed against UMAP-defined reference gates drawn by a single expert. (A) Longitudinal trajectories of correct-assignment percentages (% cells landing in the corresponding UMAP reference gate) across timepoints (Vo1 to Vo4), faceted by population (columns); the two donors are distinguished within each facet by point shape (circle, triangle) and mean-line style (solid, long-dashed). Each bold line links the per-donor mean at each timepoint (filled points, colored by method); dotted light lines are individual operator trajectories (largely overlapping and difficult to discern for PaCMAP). The y-axis is pseudo-log-scaled to resolve values near 100% (using scales::pseudo_log_trans(sigma = 0.1) in R). (B) Boxplots of correct-assignment percentages per population; boxes show the interquartile range (IQR), whiskers extend to 1.5 × IQR, white diamonds mark the group mean, and dots are individual operator × timepoint observations, colored by method and shaped by donor. (C) Boxplots of contamination percentages (% cells from a gated population landing in a non-corresponding UMAP reference gate) faceted by UMAP gated population, on a pseudo-log axis to accommodate the many zero values; boxes and dots as in (B) , with donor shown by point shape. (D) Summary of Wilcoxon rank-sum comparisons (Benjamini–Hochberg-adjusted) between methods across six metrics: correct-assignment temporal stability (SD), correct-assignment inter-rater ICC, mean contamination, proportion of zero-contamination events, contamination temporal stability (SD) and contamination inter-rater ICC; columns give each method’s group mean, the adjusted p-value and the direction; cell color indicates the significant direction (green, PaCMAP superior; orange, 2D superior; white, p ≥ 0.05). ICC (intraclass correlation coefficient) was computed with a two-way model, absolute agreement, single unit (irr::icc); groups with undefined between-operator variance were excluded as degenerate (fewer than two timepoints or three raters, or near-zero overall variance [SD < 0.01]; groups with identical values across raters were treated as perfect agreement), leaving n = 15 (PaCMAP) and n = 16 (2D) for correct assignment. Temporal-stability SD, mean contamination and the zero-contamination proportion were computed per operator and then compared between methods, isolating within-operator consistency; ICC uses the three operators as raters and therefore quantifies between-operator agreement.
    Human Ankrd49 Coding Sequence Cds, supplied by TaKaRa, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd/pDsRed2-N1+Vector/pm41821002-124-10-21
    Average 95 stars, based on 1 article reviews
    human ankrd49 coding sequence cds - by Bioz Stars, 2026-11
    95/100 stars
      Buy from Supplier

    94
    R&D Systems recombinant cd43
    Only cathepsin K degrades cell-surface mucins on K562s. A, schematic describing the flow cytometry assay used to evaluate the degradation of cell-surface mucins on K562 cells by cathepsins. B, cell viability of cells following enzymatic treatment. Normalized staining for ( C ) MUC1, ( D ) <t>CD43,</t> and ( E ) total mucins via StcE E447D following enzymatic treatments for 3 h at pH 6 in Hanks' balanced salt solution (HBSS). Staining was normalized such that PBS-treated and fluorescence minus-one controls are defined as 100% and 0% staining within each replicate ( n = 3–4 biologically independent replicates). Cathepsins have been labeled with their letter, for example, “A” refers to cathepsin A. CTSE was excluded because of the low pH of the CTSE activation buffer causing cellular toxicity . See for representative flow cytometry histograms, assays performed at pH 5 and 7, and bar graphs with raw median fluorescence intensity (MFI) values. Data are shown as mean ± SD from three to four biologically independent replicates, and each dot represents a single replicate. p Values determined via one-way ANOVA corrected via Dunnett’s multiple comparison test, with a single pooled variance. ∗ p ≤ 0.05, ∗∗ p ≤ 0.01, ∗∗∗ ≤ 0.001, and ∗∗∗∗ p ≤ 0.0001. CTSE, cathepsin E; StcE E447D , inactive point mutant of StcE used as a pan-mucin probe.
    Recombinant Cd43, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+cd/Recombinant+Human+CD43+Protein%2C+CF/pmc12969431-250-12-14
    Average 94 stars, based on 1 article reviews
    recombinant cd43 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    Image Search Results


    Comparison of PaCMAP-based and traditional 2D biaxial gating consistency for leukocyte subset identification. CD-CHEX–stabilised blood from two donors (different lots; CD1 and CD2) was gated across up to four experimental timepoints by three independent expert operators using either traditional 2D hierarchical biaxial gating (purple) or PaCMAP dimensionality-reduction-based gating (green). Gating purity was assessed against UMAP-defined reference gates drawn by a single expert. (A) Longitudinal trajectories of correct-assignment percentages (% cells landing in the corresponding UMAP reference gate) across timepoints (Vo1 to Vo4), faceted by population (columns); the two donors are distinguished within each facet by point shape (circle, triangle) and mean-line style (solid, long-dashed). Each bold line links the per-donor mean at each timepoint (filled points, colored by method); dotted light lines are individual operator trajectories (largely overlapping and difficult to discern for PaCMAP). The y-axis is pseudo-log-scaled to resolve values near 100% (using scales::pseudo_log_trans(sigma = 0.1) in R). (B) Boxplots of correct-assignment percentages per population; boxes show the interquartile range (IQR), whiskers extend to 1.5 × IQR, white diamonds mark the group mean, and dots are individual operator × timepoint observations, colored by method and shaped by donor. (C) Boxplots of contamination percentages (% cells from a gated population landing in a non-corresponding UMAP reference gate) faceted by UMAP gated population, on a pseudo-log axis to accommodate the many zero values; boxes and dots as in (B) , with donor shown by point shape. (D) Summary of Wilcoxon rank-sum comparisons (Benjamini–Hochberg-adjusted) between methods across six metrics: correct-assignment temporal stability (SD), correct-assignment inter-rater ICC, mean contamination, proportion of zero-contamination events, contamination temporal stability (SD) and contamination inter-rater ICC; columns give each method’s group mean, the adjusted p-value and the direction; cell color indicates the significant direction (green, PaCMAP superior; orange, 2D superior; white, p ≥ 0.05). ICC (intraclass correlation coefficient) was computed with a two-way model, absolute agreement, single unit (irr::icc); groups with undefined between-operator variance were excluded as degenerate (fewer than two timepoints or three raters, or near-zero overall variance [SD < 0.01]; groups with identical values across raters were treated as perfect agreement), leaving n = 15 (PaCMAP) and n = 16 (2D) for correct assignment. Temporal-stability SD, mean contamination and the zero-contamination proportion were computed per operator and then compared between methods, isolating within-operator consistency; ICC uses the three operators as raters and therefore quantifies between-operator agreement.

    Journal: Frontiers in Immunology

    Article Title: An optimized spectral flow cytometry pipeline for longitudinal blood leukocyte immunophenotyping reveals stable, individually distinct immune signatures

    doi: 10.3389/fimmu.2026.1959895

    Figure Lengend Snippet: Comparison of PaCMAP-based and traditional 2D biaxial gating consistency for leukocyte subset identification. CD-CHEX–stabilised blood from two donors (different lots; CD1 and CD2) was gated across up to four experimental timepoints by three independent expert operators using either traditional 2D hierarchical biaxial gating (purple) or PaCMAP dimensionality-reduction-based gating (green). Gating purity was assessed against UMAP-defined reference gates drawn by a single expert. (A) Longitudinal trajectories of correct-assignment percentages (% cells landing in the corresponding UMAP reference gate) across timepoints (Vo1 to Vo4), faceted by population (columns); the two donors are distinguished within each facet by point shape (circle, triangle) and mean-line style (solid, long-dashed). Each bold line links the per-donor mean at each timepoint (filled points, colored by method); dotted light lines are individual operator trajectories (largely overlapping and difficult to discern for PaCMAP). The y-axis is pseudo-log-scaled to resolve values near 100% (using scales::pseudo_log_trans(sigma = 0.1) in R). (B) Boxplots of correct-assignment percentages per population; boxes show the interquartile range (IQR), whiskers extend to 1.5 × IQR, white diamonds mark the group mean, and dots are individual operator × timepoint observations, colored by method and shaped by donor. (C) Boxplots of contamination percentages (% cells from a gated population landing in a non-corresponding UMAP reference gate) faceted by UMAP gated population, on a pseudo-log axis to accommodate the many zero values; boxes and dots as in (B) , with donor shown by point shape. (D) Summary of Wilcoxon rank-sum comparisons (Benjamini–Hochberg-adjusted) between methods across six metrics: correct-assignment temporal stability (SD), correct-assignment inter-rater ICC, mean contamination, proportion of zero-contamination events, contamination temporal stability (SD) and contamination inter-rater ICC; columns give each method’s group mean, the adjusted p-value and the direction; cell color indicates the significant direction (green, PaCMAP superior; orange, 2D superior; white, p ≥ 0.05). ICC (intraclass correlation coefficient) was computed with a two-way model, absolute agreement, single unit (irr::icc); groups with undefined between-operator variance were excluded as degenerate (fewer than two timepoints or three raters, or near-zero overall variance [SD < 0.01]; groups with identical values across raters were treated as perfect agreement), leaving n = 15 (PaCMAP) and n = 16 (2D) for correct assignment. Temporal-stability SD, mean contamination and the zero-contamination proportion were computed per operator and then compared between methods, isolating within-operator consistency; ICC uses the three operators as raters and therefore quantifies between-operator agreement.

    Article Snippet: CD-CHEX Plus stabilized human blood (213323, lots 32680071, 41550071, 50690071 and 53210071, Streck) was used as a biological-invariant control.

    Techniques: Comparison, Stability, Immunocytochemistry

    Pre-analytical handling effects on leukocyte composition and two-tier normalization. Whole blood from healthy donors was processed under varying pre-analytical conditions (n = 3 replicates per condition) and immunophenotyped by flow cytometry; populations are expressed as a percentage of total leukocytes. (A–D) Mean leukocyte subset composition (stacked bars: neutrophils, monocytes/macrophages/dendritic cells, eosinophils, B cells, T cells) per condition, with the five-population Bray–Curtis PERMANOVA result above each panel: (A) refrigerated storage at 4°C for 1, 2 or 3 days (Day 1 fresh reference; samples were pooled then split from donor 1, 4, and 6); (B) cryopreservation in CryoStor CS10 or DMSO for 15 days versus fresh (samples were split from donor 4); (C) chemical fixation analyzed at Day 1 or Day 5 versus unfixed Day 1 (samples were split from donor 4); (D) one-week-stored versus freshly prepared antibody cocktail (samples were split from donor 4). Companion data of numerical mean values in . (E–H) Two sequential leukocyte count normalization tiers were compared against raw counts for longitudinal stability. Tier 1 rescaled within-sample (to CD45 + % [%CD45], or to cells/mL by counting beads [bead] or volume [vol]); Tier 2 added a CD-CHEX-anchored cross-batch correction to remove run-to-run drift (schemes detailed in ): (E) Lineage populations of CD-CHEX, including eight major lineage populations (as described in ), were assessed for count stability over time (y-axis, Bray–Curtis dissimilarity to the first timepoint per tier, x-axis, acquisition month; lower and flatter = more stable). Each line is one normalization scheme (color) for one held-out CD-CHEX lot (line style and point shape distinguish the two lots, CHEX 3268 and CHEX 5069), with raw counts (raw) shown in every facet as a common reference; facets are the three Tier families (%CD45, bead, vol). The dashed line marks a dissimilarity of 0.1 for reference. (F) Posterior contrasts of CD-CHEX lineage count stability for each scheme versus raw counts (model below). (G) Longitudinal stability of lineage and subpopulation counts from fresh blood of 10 donors (populations as in ). X-axis, visit in chronological order; y-axis, mean Bray–Curtis dissimilarity to the first visit across donors, with the shaded ribbon the standard error across donors; each line is one scheme (color), raw counts repeated in each facet as reference; facets are level (lineages, subpopulations) × Tier family. (H) Corresponding posterior contrasts versus raw counts. In (F, H) , Bray–Curtis dissimilarity to the reference timepoint was modelled by Beta regression (brms) with normalization scheme as a fixed effect and a random intercept per population group (CD-CHEX lot in F; donor in H). Points are the posterior median difference from raw counts (ΔBray–Curtis) and bars the 80% (thick) or 95% (thin) credible interval (CI); negative values indicate greater stability than raw. A scheme was classed as more stable (green) or less stable (orange) than raw when its 95% CI excluded zero, and equivalent (gray) when it included zero. P denotes the posterior probability that a scheme has lower temporal dissimilarity than raw (the proportion of posterior draws with ΔBray–Curtis < 0), such that P = 1.00 indicates every draw favored greater stability. All models converged well (Rˆ ≤ 1.01, no divergent transitions); model convergence and fit diagnostics are given in .

    Journal: Frontiers in Immunology

    Article Title: An optimized spectral flow cytometry pipeline for longitudinal blood leukocyte immunophenotyping reveals stable, individually distinct immune signatures

    doi: 10.3389/fimmu.2026.1959895

    Figure Lengend Snippet: Pre-analytical handling effects on leukocyte composition and two-tier normalization. Whole blood from healthy donors was processed under varying pre-analytical conditions (n = 3 replicates per condition) and immunophenotyped by flow cytometry; populations are expressed as a percentage of total leukocytes. (A–D) Mean leukocyte subset composition (stacked bars: neutrophils, monocytes/macrophages/dendritic cells, eosinophils, B cells, T cells) per condition, with the five-population Bray–Curtis PERMANOVA result above each panel: (A) refrigerated storage at 4°C for 1, 2 or 3 days (Day 1 fresh reference; samples were pooled then split from donor 1, 4, and 6); (B) cryopreservation in CryoStor CS10 or DMSO for 15 days versus fresh (samples were split from donor 4); (C) chemical fixation analyzed at Day 1 or Day 5 versus unfixed Day 1 (samples were split from donor 4); (D) one-week-stored versus freshly prepared antibody cocktail (samples were split from donor 4). Companion data of numerical mean values in . (E–H) Two sequential leukocyte count normalization tiers were compared against raw counts for longitudinal stability. Tier 1 rescaled within-sample (to CD45 + % [%CD45], or to cells/mL by counting beads [bead] or volume [vol]); Tier 2 added a CD-CHEX-anchored cross-batch correction to remove run-to-run drift (schemes detailed in ): (E) Lineage populations of CD-CHEX, including eight major lineage populations (as described in ), were assessed for count stability over time (y-axis, Bray–Curtis dissimilarity to the first timepoint per tier, x-axis, acquisition month; lower and flatter = more stable). Each line is one normalization scheme (color) for one held-out CD-CHEX lot (line style and point shape distinguish the two lots, CHEX 3268 and CHEX 5069), with raw counts (raw) shown in every facet as a common reference; facets are the three Tier families (%CD45, bead, vol). The dashed line marks a dissimilarity of 0.1 for reference. (F) Posterior contrasts of CD-CHEX lineage count stability for each scheme versus raw counts (model below). (G) Longitudinal stability of lineage and subpopulation counts from fresh blood of 10 donors (populations as in ). X-axis, visit in chronological order; y-axis, mean Bray–Curtis dissimilarity to the first visit across donors, with the shaded ribbon the standard error across donors; each line is one scheme (color), raw counts repeated in each facet as reference; facets are level (lineages, subpopulations) × Tier family. (H) Corresponding posterior contrasts versus raw counts. In (F, H) , Bray–Curtis dissimilarity to the reference timepoint was modelled by Beta regression (brms) with normalization scheme as a fixed effect and a random intercept per population group (CD-CHEX lot in F; donor in H). Points are the posterior median difference from raw counts (ΔBray–Curtis) and bars the 80% (thick) or 95% (thin) credible interval (CI); negative values indicate greater stability than raw. A scheme was classed as more stable (green) or less stable (orange) than raw when its 95% CI excluded zero, and equivalent (gray) when it included zero. P denotes the posterior probability that a scheme has lower temporal dissimilarity than raw (the proportion of posterior draws with ΔBray–Curtis < 0), such that P = 1.00 indicates every draw favored greater stability. All models converged well (Rˆ ≤ 1.01, no divergent transitions); model convergence and fit diagnostics are given in .

    Article Snippet: CD-CHEX Plus stabilized human blood (213323, lots 32680071, 41550071, 50690071 and 53210071, Streck) was used as a biological-invariant control.

    Techniques: Flow Cytometry, Stability, Counting

    Only cathepsin K degrades cell-surface mucins on K562s. A, schematic describing the flow cytometry assay used to evaluate the degradation of cell-surface mucins on K562 cells by cathepsins. B, cell viability of cells following enzymatic treatment. Normalized staining for ( C ) MUC1, ( D ) CD43, and ( E ) total mucins via StcE E447D following enzymatic treatments for 3 h at pH 6 in Hanks' balanced salt solution (HBSS). Staining was normalized such that PBS-treated and fluorescence minus-one controls are defined as 100% and 0% staining within each replicate ( n = 3–4 biologically independent replicates). Cathepsins have been labeled with their letter, for example, “A” refers to cathepsin A. CTSE was excluded because of the low pH of the CTSE activation buffer causing cellular toxicity . See for representative flow cytometry histograms, assays performed at pH 5 and 7, and bar graphs with raw median fluorescence intensity (MFI) values. Data are shown as mean ± SD from three to four biologically independent replicates, and each dot represents a single replicate. p Values determined via one-way ANOVA corrected via Dunnett’s multiple comparison test, with a single pooled variance. ∗ p ≤ 0.05, ∗∗ p ≤ 0.01, ∗∗∗ ≤ 0.001, and ∗∗∗∗ p ≤ 0.0001. CTSE, cathepsin E; StcE E447D , inactive point mutant of StcE used as a pan-mucin probe.

    Journal: The Journal of Biological Chemistry

    Article Title: The protease cathepsin K can debulk the cancer glycocalyx

    doi: 10.1016/j.jbc.2026.111206

    Figure Lengend Snippet: Only cathepsin K degrades cell-surface mucins on K562s. A, schematic describing the flow cytometry assay used to evaluate the degradation of cell-surface mucins on K562 cells by cathepsins. B, cell viability of cells following enzymatic treatment. Normalized staining for ( C ) MUC1, ( D ) CD43, and ( E ) total mucins via StcE E447D following enzymatic treatments for 3 h at pH 6 in Hanks' balanced salt solution (HBSS). Staining was normalized such that PBS-treated and fluorescence minus-one controls are defined as 100% and 0% staining within each replicate ( n = 3–4 biologically independent replicates). Cathepsins have been labeled with their letter, for example, “A” refers to cathepsin A. CTSE was excluded because of the low pH of the CTSE activation buffer causing cellular toxicity . See for representative flow cytometry histograms, assays performed at pH 5 and 7, and bar graphs with raw median fluorescence intensity (MFI) values. Data are shown as mean ± SD from three to four biologically independent replicates, and each dot represents a single replicate. p Values determined via one-way ANOVA corrected via Dunnett’s multiple comparison test, with a single pooled variance. ∗ p ≤ 0.05, ∗∗ p ≤ 0.01, ∗∗∗ ≤ 0.001, and ∗∗∗∗ p ≤ 0.0001. CTSE, cathepsin E; StcE E447D , inactive point mutant of StcE used as a pan-mucin probe.

    Article Snippet: Recombinant PSGL-1 (10 μg; Sino Biological; 13863-H08H), recombinant MUC1 (Sino Biological; 12123-H05H), recombinant CD43 (R&D Systems; 9680-CD-050), fetuin (Promega; V4961), and purified MUC16 (purified from OVCAR-3 as above) were mixed with CTSK or PBS control at a 1:50 CTSK:substrate molar ratio in 1:1 PBS:100 mM sodium acetate with a final pH of 5 (buffer pHed as above).

    Techniques: Flow Cytometry, Staining, Fluorescence, Labeling, Activation Assay, Comparison, Mutagenesis